![](/img/cover-not-exists.png)
Feasibility and cost–benefit of implementing pooled screening for HCVAg in small blood bank settings
B. Sarov, L. Novack, N. Beer, J. Safi, H. Soliman, J. S. Pliskin, E. Litvak, A. Yaari, E. ShinarVolume:
17
Year:
2007
Language:
english
DOI:
10.1111/j.1365-3148.2007.00790.x
File:
PDF, 198 KB
english, 2007